Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

13 Canadian Crypto ETFs (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

Can You Invest in Elon Musk’s Neuralink? (Updated 2024)

Top 4 Largest Lithium Reserves by Country (Updated 2024)

Top 10 Countries for Natural Gas Production (Updated 2024)

Trending Press Releases

Radiopharm achieves Nasdaq listing of ADS

First Helium Reviewing Potential Follow Up Targets to Leduc Anomaly Drill

HyProMag USA Feasibility Study Demonstrates Robust Economics and the Opportunity to Develop a Major New, Domestic Source of Recycled Rare Earths Magnets for the United States

First Helium Confirms Plans for Sequential Drilling of Two Oil Targets - Proven Undeveloped Oil Location and Large Leduc Anomaly

CHARBONE Hydrogen Announces a First Closing of its $1M Non-Brokered Private Placement

Silver47 Drills 2.66 Metres of 1,801 g/t Silver Equivalent within 22.3 Metres of 601 g/t Silver Equivalent at its Red Mountain Project, Alaska

More Press Releases
Trending Companies

First Helium

HELI:CA

Purpose Bitcoin ETF

BTCC:CA

Soma Gold Corp.

SOMA:CA

Black Swan Graphene

SWAN:CC
More Companies
Trending Reports

2024 Gold Outlook Report

2024 Graphite Outlook Report

2024 Lithium Market Outlook

2024 Uranium Outlook

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence

Psychedelics Investing: World

Coverage of the psychedelics market for global investors, including news, analysis forecasts, and stock updates.

Psychedelic mushrooms.
Psychedelics Investing

Psychedelics Market Update: H1 2024 in Review

The psychedelics sector continues to attract investor attention. What trends moved the market in the first half of 2024?

psychedelics outlookpsychedelics investingPsychedelics Investing
Latest Articles

FDA Finds Kratom Capsules Safe, but Questions About Concentrated Forms Remain

psychedelics investingPsychedelics Investing

Psychedelics Market Forecast: Top Trends That Will Affect Psychedelics in 2024

psychedelics outlookpsychedelics investingPsychedelics Investing

Psychedelics Market 2023 Year-End Review

psychedelics investingpsychedelics stockspsychedelics outlookPsychedelics Investing

How to Invest in Psychedelics

psychedelics investingpsychedelics outlookpsychedelics stocksPsychedelics Investing

Psychedelics Stocks to Watch

psychedelics investingcse stocksnasdaq stocksotc stockspsychedelics stockstsx stockstsxv stocksPsychedelics Investing

Psychedelics Market Forecast: 3 Top Trends That Will Affect Psychedelics in 2023

financepsychedelics outlooktradingpsychedelics investingPsychedelics Investing
Company Profiles

Fungtional Labs

Integrated supply chain for mushroom cultivators in North America

psychedelics investingpharmaceutical investingPharmaceutical Investing
LITT:CC

Roadman Investments

PLNT.X:CC

Better Plant Sciences

More Companies
CEO Interviews

Silo Wellness CEO Sees Market Traction for Psychedelic Healing

cse stockscse:silosilo wellnesspsychedelics investingPsychedelics Investing

Orphan Drug Development an Exciting Opportunity to Provide Superior Therapeutics, Lobe Sciences CEO Says

psychedelics investingcse stockscse:lobelobe sciencespharmaceutical investingPharmaceutical Investing

Albert Labs Eyes One Dose Psilocybin Treatment for Cancer-related Anxiety

pharmaceutical investingpsychedelics investingalbert labscse stockscse:abrtPsychedelics Investing
Trending

Functional Mushrooms: A Market Overview

pharmaceutical stockspsychedelics investingpharmaceutical investingpsychedelics stocksPharmaceutical Investing

The Business Case for Vertical Integration

pharmaceutical stockspsychedelics investingpharmaceutical investingPharmaceutical Investing

Functional Mushrooms: A Growing Opportunity

psychedelics investingpharmaceutical investingPharmaceutical Investing
psychedelics News
Emyria Limited (ASX:EMD)

Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

Psychedelics Investing
Quantum Biopharma (CSE:QNTM)

Quantum BioPharma Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing

Psychedelics Investing
Awakn Life Sciences Corp. (CSE:AWKN)

Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites

Psychedelics Investing
Melodiol Global Health (ASX:ME1)

Quarterly Activities Report: Melodiol Delivers $9.3m in Revenue During H1 FY24 – a 33% Increase the PCP

Psychedelics Investing
Melodiol Global Health Limited (ASX:ME1)

Corporate Update

psychedelics investing
Melodiol Global Health Limited (ASX:ME1)

Melodiol Global Health Limited (ASX: ME1) – Trading Halt

psychedelics investing
Melodiol Global Health Limited (ASX:ME1)

Mernova Q3 Revenue Update

psychedelics investing
Melodiol Global Health Limited (ASX:ME1)

$12M Proposed Cash Asset Sale to Strengthen Balance Sheet, with $2.2M of Earn Outs

psychedelics investing
Melodiol Global Health Limited (ASX:ME1)

Melodiol Q2 Revenue and Updates

psychedelics investing
Melodiol Global Health Limited (ASX:ME1)

Corporate Update

psychedelics investing
Fungtional Labs

Fungtional Labs: Integrated Supply Chain for Mushroom Cultivators in North America

Pharmaceutical Investing
Melodiol Global Health Limited (ASX:ME1)

Mernova’s Strong Progress Continues

psychedelics investing
Melodiol Global Health Limited (ASX:ME1)

Notice of Annual General Meeting/Proxy Form

psychedelics investing
Melodiol Global Health Limited (ASX:ME1)

Quarterly Activities Report: Melodiol Delivers $4.4M in Revenue during Q1 FY24 – a 91% Increase the PCP

psychedelics investing
Melodiol Global Health Limited (ASX:ME1)

Q1 FY24 Revenue Update

psychedelics investing
More psychedelics News
Editors' Picks
Psychedelics Investing

Psychedelics Market 2022 Year-End Review

Psychedelics Investing

How Do Psychedelics Clinical Trials Work?

Psychedelics Investing

Morgan Stanley Positive in First Psychedelics Research Report

Latest psychedelics News

More psychedelics News
×